Salarius Pharmaceuticals Inc (NASDAQ:SLRX)

North American company
add to virtual portfolio
This share can be held in
Trading AccountISAJISASIPP

Share Price Chart

- Chart currently unavailable -

Market Info - SLRX

  • Market Open Price0.00
  • Previous Close0.00
  • Volume-
  • 52w Low/High-
  • Last Trade Price0.00
  • Bid/Ask Price0.00

Company Info - SLRX

  • Market Cap$52.380m
  • IndustryHealthcare
  • SectorBiotechnology
  • Currency
  • ISINUS79400X1072

Company Profile

Salarius Pharmaceuticals Inc is a clinical-stage biotechnology company focused on developing effective treatments for cancers with high, unmet medical need. It is engaged in developing treatments for cancers caused by dysregulated gene expression. The company's lead epigenetic-based technology, seclidemstat (SP-2577) is a small molecule, administered orally, that inhibits the epigenetic enzyme lysine specific demethylase 1.Flex Pharma Inc is a biotechnology company. The company is engaged in developing proprietary treatments for nocturnal leg cramps and spasms associated with severe neuromuscular conditions.

Latest SLRX news

Currently there for this company. Visit our news hub for other news .